Impact of COVID-19 on Acute Myocardial Infarction Care

Guddeti, Raviteja; Yıldız, Mehmet; Nayak, Keshav R.; Alraies, M. Chadi; Davidson, Laura; Henry, Timothy D.; García, Santiago

doi:10.1016/j.ccl.2022.03.004

Cited by 9 publications

(6 citation statements)

References 47 publications

(84 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 25 Previous reports have demonstrated a delay and/or complexities in care due to sheer volume and immensely stretched resources during the peak of pandemic. 2 , 26 …”

Section: Discussionmentioning

confidence: 99%

Nationwide Analysis of Cardiac Arrest Outcomes During the COVID-19 Pandemic

Isath

Malik

Bandyopadhyay

et al. 2023

Current Problems in Cardiology

View full text Add to dashboard Cite

“… 25 Previous reports have demonstrated a delay and/or complexities in care due to sheer volume and immensely stretched resources during the peak of pandemic. 2 , 26 …”

Section: Discussionmentioning

confidence: 99%

Nationwide Analysis of Cardiac Arrest Outcomes During the COVID-19 Pandemic

Isath

Malik

Bandyopadhyay

et al. 2023

Current Problems in Cardiology

View full text Add to dashboard Cite

“…Both in Canada and the US, as occurred globally, the COVID-19 pandemic adversely impacted STEMI care. 13 , 14 On the background of traditionally different health care systems and compounded by differences in how the pandemic was managed in Canada and the US, understanding how STEMI outcomes compare between these 2 countries has health policy implications. Various pre-COVID-19 comparisons have historically described how variations in health care between Canada and the US are associated with STEMI presentations and outcomes.…”

Section: Discussionmentioning

confidence: 99%

Comparative Analysis of Patients With STEMI and COVID-19 Between Canada and the United States

Shavadia

Stanberry

Singh

et al. 2023

Journal of the Society for Cardiovascular Angiography & Int

Self Cite

View full text Add to dashboard Cite

“…Similar to the observations made with HF hospitalizations at the onset of the pandemic, hospitalizations for chest pain and acute coronary syndromes (ACS) fell precipitously at the onset of the pandemic-including a marked reduction in ST-segment elevation myocardial infarction (STEMI) activations and primary percutaneous coronary intervention (PCI) volumes. 89,[131][132][133] Furthermore, a significant fall in emergency transfers for acute cardiovascular conditions, including STEMI, was identified in Cleveland in March through May of 2020. 134 Despite this, interventional cardiologists prepared to adapt to a changing landscape in the delivery of cardiac catheterization laboratory (CCL) care through guidance put forth by professional societies on how to approach STEMI, non-ST-segment elevation myocardial infarction, and elective interventions.…”

Section: Acute Coronary Syndromes and Cardiac Catheterization Laborat...mentioning

confidence: 99%

“…170,171 The need for mechanical circulatory support in COVID-19 STEMI patients who developed cardiogenic shock was also associated with excessive mortality rates. 133,172 The decision to pursue these aggressive interventions in this population should be highly selective and offered after consideration by a multidisciplinary team. [172][173][174]…”

Section: Acute Coronary Syndromes and Cardiac Catheterization Laborat...mentioning

confidence: 99%

Interaction of COVID-19 With Common Cardiovascular Disorders

Boulos

Freeman

Henry

et al. 2023

Circulation Research

Self Cite

View full text Add to dashboard Cite

The onset and widespread dissemination of the severe acute respiratory syndrome coronavirus-2 in late 2019 impacted the world in a way not seen since the 1918 H1N1 pandemic, colloquially known as the Spanish Flu. Much like the Spanish Flu, which was observed to disproportionately impact young adults, it became clear in the early days of the coronavirus disease 2019 (COVID-19) pandemic that certain groups appeared to be at higher risk for severe illness once infected. One such group that immediately came to the forefront and garnered international attention was patients with preexisting cardiovascular disease. Here, we examine the available literature describing the interaction of COVID-19 with a myriad of cardiovascular conditions and diseases, paying particular attention to patients diagnosed with arrythmias, heart failure, and coronary artery disease. We further discuss the association of acute COVID-19 with de novo cardiovascular disease, including myocardial infarction due to coronary thrombosis, myocarditis, and new onset arrhythmias. We will evaluate various biochemical theories to explain these findings, including possible mechanisms of direct myocardial injury caused by the severe acute respiratory syndrome coronavirus-2 virus at the cellular level. Finally, we will discuss the strategies employed by numerous groups and governing bodies within the cardiovascular disease community to address the unprecedented challenges posed to the care of our most vulnerable patients, including heart transplant recipients, end-stage heart failure patients, and patients suffering from acute coronary syndromes, during the early days and height of the COVID-19 pandemic.

show abstract

Impact of COVID-19 on Acute Myocardial Infarction Care

Cited by 9 publications

References 47 publications

Nationwide Analysis of Cardiac Arrest Outcomes During the COVID-19 Pandemic

Nationwide Analysis of Cardiac Arrest Outcomes During the COVID-19 Pandemic

Comparative Analysis of Patients With STEMI and COVID-19 Between Canada and the United States

Interaction of COVID-19 With Common Cardiovascular Disorders

Contact Info

Product

Resources

About